<DOC>
	<DOCNO>NCT00385021</DOCNO>
	<brief_summary>To determine efficacy delivery chronomodulated chemotherapy .</brief_summary>
	<brief_title>ChronoFOLFOX Plus Avastin Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description>The purpose study determine treatment 5-Fluorouracil , leucovorin , oxaliplatin , Avastin cause colorectal tumor cell shrink disappear . The study also determine safety drug give together quality life patient enrol study . It think drug well tolerate chronomodulated , i.e. , give certain time day rather continuous infusion .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Histological proof adenocarcinoma primary colon rectum tumor . Evidence metastatic colorectal cancer locoregional recurrence unresectable disease . Ages 18 86 year . Presence least one bidimensionally measurable disease least one diameter &gt; = 2 cm . WHO/ECOG performance status &lt; 3 ( 0 , 1 , 2 ) Prior treatment oxaliplatin , 5FU , leucovorin permit . Signed informed consent Peripheral sensory neuropathy &gt; = grade 3 . Serum bilirubin ( total ) &gt; 3 X ULN . Symptomatic uncontrolled brain metastasis . Metastases limit bone , pleural effusion , ascites . Uncontrolled overt cardiac disease . Uncontrolled hypercalcemia . Uncontrolled infection . Uncontrolled hypertension ( &gt; 180/110 ) History GI perforation . History arterial thromboembolic event . History congestive heart failure . Patients take warfarin ( Coumadin ) . Patients pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>86 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Advanced</keyword>
	<keyword>metastatic</keyword>
	<keyword>colorectal</keyword>
	<keyword>cancer</keyword>
	<keyword>Avastin</keyword>
</DOC>